Archive for April 2021
SARS-CoV-2 Transmission To, From, and Among Children: What’s New?
SARS-CoV-2 Transmission To, From, and Among Children: What’s New? April 30, 2021 The dynamics of infection of children has been of great interest, particularly as it pertains to the issue of whether or not to open schools and to vaccinate children. The discussions have at times been contentious. There are multiple aspects to the issue.…
Read MoreGVN Center and Member Spotlight – Akhil Banerjea
Members > Spotlights > Akhil Banerjea GVN Center and Member Spotlight Akhil Banerjea Emeritus Scientist Institute of Advanced Virology, GVN Affiliate Trivandrum, Kerala, India What are you and your institution currently working on regarding COVID-19 I am the Director at Institute of Advanced Virology, Trivandrum, Kerala, India. This institute focuses on studying viruses causing infectious…
Read MoreSenegal
WELCOME TO Senegal Center of Excellence Senegal For an overview of GVN Centers of Excellence, click here. Institut de Recherche en SantĂ©, de Surveillance EpidĂ©miologique et de Formation , or IRESSEF Arrondissement 4, Rue 2D1, Pole Urbain de Diamniadio, BP 7325, Dakar 20000, Senegal Center Director: Dr. Souleymane Mboup Member Researchers: Professor Coumbe Toure Kane,…
Read MoreGVN Regional Headquarters
GVN Regional Headquarters Overview The overall mission of a GVN Regional Headquarters office is to collaborate with the GVN global headquarters located in Baltimore, Maryland, USA. A GVN Regional HQ provides organizational support and leadership to strengthen basic and translational research in virology, as well as preparedness and response to viral pandemic threats. Responsibilities Acting…
Read MoreUnderstanding Multisystem Inflammatory Syndrome in Children with COVID-19
Understanding Multisystem Inflammatory Syndrome in Children with COVID-19 April 16, 2021 Multisystem inflammatory syndrome in children (MIS-C) is a rare but is severe hyperinflammatory condition in children and adolescents. It is also known as pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.  This typically occurs 2–6 weeks after acute SARS-CoV-2 infection. Symptoms include persistent fever,…
Read MoreVaccine Safety
COVID-19 Vaccine Safety Risk The health agencies approved COVID-19 vaccines under emergency use authorization by reviewing the data (safety and protective efficacy) from clinical trials. However, we have encountered unexpected adverse events with certain vaccines since the vaccine rollout. The GVN is updating current status of using these vaccines. A rare blood clot with low…
Read MoreCOVID-19 Vaccine for Long-Haulers: A Surprising Benefit?
COVID-19 Vaccine for Long-Haulers: A Surprising Benefit? April 9, 2021 We are in the COVID-19 pandemic over one year now and still learning something new about SARS-CoV-2 and COVID-19. One of the serious and mysterious aspects of COVID-19 is long-term symptoms that persist for a significant period after SARS-CoV-2 infection as previously discussed. Many patients…
Read MoreGlobal Virus Network (GVN) Announces Eight Distinguished International Appointments to Board of Directors
World Leaders in Business, Science, Law, Industry, Philanthropy & Government Are Committed to Supporting the GVN Baltimore, MD, USA (April 6, 2021) – The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, today announced the election of eight distinguished…
Read MoreA Statement From the Leadership of the Global Virus Network on the Passing of Dr. John Martin
An Outstanding Clinical Scientist, A Dedicated Humanitarian, An Astute Businessman, An Effective Global Leader, and A True Friend Baltimore, MD, April 1, 2021: The Global Virus Network, the world’s leading coalition of virologists combatting current and emerging pandemic viral threats and viral causes of disease through international collaborative research response, mourns the passing of its good friend…
Read More